DELETE eReport June 29, 2021

Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients

Robert L. Findling, MD, MBA

J Clin Psychiatry 2021;82(4):SU20014BR2C

Bipolar depression in youth has a negative effect on numerous domains, including physical and emotional well-being, school and family functioning, friendships, and academic success. Early treatment is crucial, yet diagnosis is difficult. The standard of treatment often requires life-long psychopharmacological management, and most treatments increase risk of adverse effects. Pediatric patients who have at least 1 parent with bipolar disorder are considered to be at higher risk for also developing bipolar depression, although there is currently no clear evidence of efficacious pharmacotherapy for these patients.

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

To cite: Findling RL. Diagnosis and pharmacotherapy of bipolar depression in pediatric patients. J Clin Psychiatry. 2021;82(4):SU20014BR2C.
To share: https://doi.org/10.4088/JCP.SU20014BR2C

© Copyright 2021 Physicians Postgraduate Press, Inc.

aVirginia Commonwealth University School of Medicine, Richmond

 

CME LogoCME Logo

View Related Activity

Go to Activity